Perpetual Ltd’s Jazz Pharmaceuticals JAZZ Stock Holding History

Perpetual Ltd’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$23.7M	Sell	102,408 -1,856	-2%	-$459K	0.36%	76
2026 Q2	$25.1M	Sell	104,264 -36,621	-26%	-$8.02M	0.36%	82
2026 Q1	$26.6M	Sell	140,885 -13,765	-9%	-$2.41M	0.41%	65
2025 Q4	$26.3M	Sell	154,650 -447,997	-74%	-$68.7M	0.38%	66
2025 Q3	$79.4M	Sell	602,647 -284,936	-32%	-$34.2M	0.99%	30
2025 Q2	$94.2M	Sell	887,583 -64,589	-7%	-$7.02M	1.11%	25
2025 Q1	$118M	Buy	952,172 +357,784	+60%	+$46.7M	1.43%	19
2024 Q4	$73.2M	Sell	594,388 -81,043	-12%	-$9.6M	0.86%	42
2024 Q3	$75.2M	Buy	675,431 +63,564	+10%	+$6.97M	0.82%	44
2024 Q2	$65.3M	Buy	611,867 +136,849	+29%	+$15M	0.71%	51
2024 Q1	$57.2M	Buy	475,018 +166,543	+54%	+$20.4M	0.56%	55
2023 Q4	$37.9M	Buy	308,475 +80,775	+35%	+$10.1M	0.39%	59
2023 Q3	$29.5M	Buy	227,700 +155,325	+215%	+$20.7M	0.3%	68
2023 Q2	$8.97M	Buy	+72,375	New	+$9.7M	0.08%	147

Other funds holding JAZZ

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Polaris Capital Management Boston, Massachusetts $953M AUM 27.74% 1-Year Est. Return

Argent Capital Management St Louis, Missouri $3.14B AUM 31.36% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Perpetual Ltd's JAZZ Position: Q3 2026 in Review

Perpetual Ltd reduced its Jazz Pharmaceuticals (JAZZ) stake by 1.8% in Q3 2026, selling an estimated $459K and leaving 102,408 shares worth $23.7M. The position accounts for 0.36% of the portfolio, ranked #76.

Perpetual Ltd first reported a position in JAZZ in Q2 2023 and has held it in 14 quarters since. The position peaked at $118M in Q1 2025. 134 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.

Perpetual Ltd held 102,408 shares of Jazz Pharmaceuticals worth $23.7M as of Q3 2026.
Perpetual Ltd sold 1,856 Jazz Pharmaceuticals shares in Q3 2026, an estimated $459K.
Jazz Pharmaceuticals made up 0.36% of Perpetual Ltd's portfolio in Q3 2026, its #76 holding.
Perpetual Ltd first reported a position in Jazz Pharmaceuticals in Q2 2023 and has held it in 14 quarters since.
Perpetual Ltd's Jazz Pharmaceuticals position peaked at $118M in Q1 2025.
134 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.

Based on Perpetual Ltd's 13F filing for Q3 2026, filed 13 Oct 2026.